Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
wikitox:non_sedating_antihistamines [2025/06/03 00:23] – kharris | wikitox:non_sedating_antihistamines [2025/06/03 02:17] (current) – kharris | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== | + | ====== |
---- | ---- | ||
Line 50: | Line 50: | ||
* **ECG**: looking for QT prolongation | * **ECG**: looking for QT prolongation | ||
- | |||
===== TREATMENT ===== | ===== TREATMENT ===== | ||
Line 74: | Line 73: | ||
**Give: 50g Activated Charcoal (Child: 1g/kg, max 50g) ** | **Give: 50g Activated Charcoal (Child: 1g/kg, max 50g) ** | ||
+ | |||
==== Enhanced Elimination ==== | ==== Enhanced Elimination ==== | ||
Line 90: | Line 90: | ||
===== REFERENCES ===== | ===== REFERENCES ===== | ||
- | - Poluzzi E, Raschi E, Godman B, Koci A, Moretti U, Kalaba M, et al. Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe. PLoS One 2015; | + | - Poluzzi E, Raschi E, Godman B, Koci A, Moretti U, Kalaba M, et al. Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe. PLoS One 2015; |